Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 3/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.31 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3847664 | 0.89 | NPC1 (0.34) | PIK3CAPIK3CBMTORCDK19TGFBR1 | |
| SCHEMBL3847148 | 0.86 | — | — | |
| SCHEMBL3852556 | 0.84 | TGFBR1 (0.34) | PIK3CAPIK3CBMTORCDK19TGFBR1 | |
| SCHEMBL3845667 | 0.84 | KIT (0.36) | PIK3CAPIK3CBMTORCDK19TGFBR1 | |
| SCHEMBL3847453 | 0.84 | TGFBR1 (0.35) | PIK3CAPIK3CBMTORCDK19TGFBR1 | |
| SCHEMBL3856480 | 0.82 | TGFBR1 (0.36) | PIK3CAPIK3CBMTORCDK19TGFBR1 | |
| SCHEMBL3851330 | 0.81 | PIK3CA (0.39) | PIK3CAPIK3CBMTORCDK19TGFBR1 | |
| SCHEMBL3846927 | 0.79 | FLT3 (0.43) | PIK3CATGFBR1 | |
| SCHEMBL3846832 | 0.78 | TGFBR1 (0.37) | PIK3CAPIK3CBMTORCDK19TGFBR1 | |
| SCHEMBL3856378 | 0.77 | TGFBR1 (0.36) | PIK3CAPIK3CBMTORCDK19TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2048142-A2 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | Eisai R&D Management Co., Ltd. (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-1382603-B1 | NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | EISAI R&D MAN CO LTD (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-7074801-B1 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | EISAI CO., LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-1382603-A1 | NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | Eisai Co., Ltd. (JP) | 2004-01-21 | — | — | EP | disclosed |